Clinical Trial Update: Study to Evaluate Safety and Efficacy of SYHX1901 Tablets in Severe Alopecia Areata Patients [Phase 2]

View source ↗

Summary

Phase 2 trial to evaluate the safety and efficacy of SYHX1901 tablets in severe alopecia areata; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• SYHX1901 Tablets (SYHX1901)

Snippet

Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd. | Conditions: Severe Alopecia Areata | Phase 2 | Status: NOT_YET_RECRUITING